InvestSMART

Montaka Global Extension Fund (Quoted Managed Hedge Fund) (ASX: MKAX) - Announcements

- Current share price for MKAX : $3.950

Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX) is a global equities manager with offices in Sydney, Melbourne and New York. The Fund seeks to invest in a portfolio of high-quality global equities listed on major global exchanges (the Long Portfolio) purchased at a discount to our estimate of their intrinsic value.

Latest company announcements for Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$78 MKAX - Monthly Redemption and Units on Issue - May 22 7 Jun 2022 2:50PM $2.700 $3.950 risen by 46.30%
$78 MKAX Quarterly Portfolio Disclosure - 31 March 22 31 May 2022 3:03PM $2.630 $3.950 risen by 50.19%
$78 MKAX Apr22 Investment Report 9 May 2022 12:22PM $2.780 $3.950 risen by 42.09%
$78 MKAX - Monthly Redemption and Units on Issue - April 22 5 May 2022 5:37PM $2.780 $3.950 risen by 42.09%
$78 MKAX - Monthly Prime Brokerage Disclosure - April 22 5 May 2022 3:07PM $2.770 $3.950 risen by 42.60%
$78 MKAX PDS April 2022 29 Apr 2022 8:09AM $2.670 $3.950 risen by 47.94%
$78 MKAX - Investor Notice 29.04.2022 29 Apr 2022 8:09AM $2.670 $3.950 risen by 47.94%
$78 MKAX - Monthly Redemption and Units on Issue - 31 March 22 7 Apr 2022 1:26PM $3.180 $3.950 risen by 24.21%
$78 MKAX - Monthly Prime Brokerage - 31 March 22 7 Apr 2022 1:23PM $3.180 $3.950 risen by 24.21%
$78 MKAX FY22 Half-year Audit 11 Mar 2022 3:49PM $2.830 $3.950 risen by 39.58%
$78 MKAX Feb22 Investment Report 8 Mar 2022 2:49PM $2.760 $3.950 risen by 43.12%
$78 MKAX - Monthly Redemption and Units on Issue - 28 Feb 22 7 Mar 2022 12:24PM $2.950 $3.950 risen by 33.90%
$78 MKAX - Monthly Prime Brokerage Disclosure - 28 Feb 22 7 Mar 2022 12:24PM $2.950 $3.950 risen by 33.90%
$78 MKAX Quarterly Portfolio Disclosure - 31 Dec 2021 28 Feb 2022 5:32PM $3.070 $3.950 risen by 28.66%
$78 RG240 disclosures for MKAX June 2021 22 Feb 2022 11:26AM $3.120 $3.950 risen by 26.60%
$78 MKAX Investment Report 31 January 2022 8 Feb 2022 8:19AM $3.470 $3.950 risen by 13.83%
$78 MKAX - Monthly Net Redemption and Units on Issue - 31 Jan 22 7 Feb 2022 2:15PM $3.470 $3.950 risen by 13.83%
$78 MKAX - Monthly Prime Brokerage Disclosure - 31 Jan 2022 7 Feb 2022 12:33PM $3.470 $3.950 risen by 13.83%
$78 Quarterly Letter to Shareholders Dec2021 20 Jan 2022 2:04PM $3.390 $3.950 risen by 16.52%
$78 MKAX Report December 2021 20 Jan 2022 1:41PM $3.390 $3.950 risen by 16.52%
$78 MKAX - Final Distribution - 31 Dec 2021 17 Jan 2022 12:33PM $3.510 $3.950 risen by 12.54%
$78 MKAX - Monthly Prime Brokerage Disclosure - 31 December 21 10 Jan 2022 3:18PM $3.560 $3.950 risen by 10.96%
$78 MKAX - Monthly Net Redemption and Units on Issue - 31 Decemb 10 Jan 2022 11:58AM $3.560 $3.950 risen by 10.96%
$78 MKAX -Distribution - 31 December 2021 21 Dec 2021 8:54AM $3.950 $3.950 fallen by 0%
$78 MKAX Investment Report November 2021 7 Dec 2021 5:36PM $4.060 $3.950 fallen by 2.71%

151 - 175 of 231 results

Page 7 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.